State-owned pharmaceutical group Saïdal has begun the phased restart of production lines at the former Hup Pharma facility in Constantine, Algeria. The plant had been inactive for three years prior to this resumption. This restart signals a potential boost to Algeria's domestic pharmaceutical production capacity. Details regarding the specific products and full production timeline remain limited, but the move is viewed positively for regional employment and healthcare access. The reopening aims to address local demand and potentially reduce reliance on imported medications. Further updates are expected as production increases at the Constantine facility. This development is a significant step for the Algerian pharmaceutical industry.